Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Lidocaine and Moisturizer in Atopic Dermatitis
NCT07067541Completed
- Sponsor
- First Affiliated Hospital of Kunming Medical University
- Start
- Oct 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of lidocaine 10% oropharyngeal spray in atopic dermatitis (AD) (2 arms), sponsored by First Affiliated Hospital of Kunming Medical University. Primary endpoint: SCORing Atopic Dermatitis at 4 weeks. Started Oct 2023; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07067541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07067541.